Oxford AstraZeneca vaccine granted Emergency Use Listing : WHO

▴ Oxford AstraZeneca vaccine granted Emergency Use Listing : WHO
As the vaccine earns approval from WHO now it is eligible for distribution in low and middle-income countries

Paving the way for Covid-19 vaccines to be distributed to low-income countries, the World Health Organisation on Monday granted emergency use listing (EUL) for the Oxford-Astrazeneca coronavirus vaccine manufactured by India's Serum Institute and South Korea's AstraZeneca-SKBio.

The authorisation will allow SII, the world’s biggest vaccine maker, to begin supplies of the Oxford vaccine to the WHO-backed COVAX initiative. Some 190 countries have joined the programme, which was established to ensure equitable distribution of vaccines.

Earlier, Serum Institute CEO Adar Poonawalla had said it would sell each dose at $3 for low-income countries. Besides the Oxford vaccine, WHO listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31.

The approval came after WHO's Strategic Advisory Group of Experts on Immunization (SAGE) reviewed the vaccine on February 8. The SAGE has recommended the vaccine for all age groups 18 and above.

"Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution," Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products, said in a statement.

What does emergency use listing by WHO mean?
An EUL by WHO is an endorsement of sorts that will enable speedy pick-up of the vaccine by countries that lack an elaborate regulatory setup. According to WHO, its Emergency Use Listing assesses the quality, safety and efficacy of Covid-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 vaccines.

In the case of the AstraZeneca/Oxford vaccine, WHO assessed the quality, safety and efficacy data, risk management plans and programmatic suitability, such as cold chain requirements, the statement said. The process took four weeks.

Story Credit

https://www.indiatoday.in/coronavirus-outbreak/story/serum-institute-who-emergency-use-listing-oxford-covid-vaccine-1769586-2021-02-15 

Tags : #OxfordUniversity #AstraZeneca #WHO #VaccineApproval #LowandMiddleincomeCountries #SerumInstitute #AdarPoonawala

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024